NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® ...
Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI) ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Scrip and save. Companies that introduce scrip dividends to reward investors and boost headline payout figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback